{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:54:24Z","timestamp":1788526464784,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-023-02104-2","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:01:40Z","timestamp":1691539300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4225-110X","authenticated-orcid":false,"given":"Shinsuke","family":"Muraoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shimato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Koketsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"2104_CR1","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1161\/STROKEAHA.120.029279","volume":"51","author":"A Anetsberger","year":"2020","unstructured":"Anetsberger A, Gempt J, Blobner M et al (2020) Impact of goal-directed therapy on delayed ischemia after aneurysmal subarachnoid hemorrhage: randomized controlled trial. Stroke 51:2287\u20132296. https:\/\/doi.org\/10.1161\/STROKEAHA.120.029279","journal-title":"Stroke"},{"key":"2104_CR2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00701-007-1249-3","volume":"149","author":"M Barth","year":"2007","unstructured":"Barth M, Capelle HH, M\u00fcnch E et al (2007) Effects of the selective endothelin A (ET(A)) receptor antagonist clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series. Acta Neurochir (Wien) 149:911\u2013918. https:\/\/doi.org\/10.1007\/s00701-007-1249-3","journal-title":"Acta Neurochir (Wien)"},{"key":"2104_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/01.sla.0000094387.50865.23","volume":"238","author":"B Brandstrup","year":"2003","unstructured":"Brandstrup B, T\u00f8nnesen H, Beier-Holgersen R, Hjorts\u00f8 E, \u00d8rding H, Lindorff-Larsen K et al (2003) Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 238:641\u2013648. https:\/\/doi.org\/10.1097\/01.sla.0000094387.50865.23","journal-title":"Ann Surg"},{"key":"2104_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12028-011-9598-4","volume":"15","author":"N Bruder","year":"2011","unstructured":"Bruder N, Rabinstein A, Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage (2011) Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurocrit Care 15:257\u2013269. https:\/\/doi.org\/10.1007\/s12028-011-9598-4","journal-title":"Neurocrit Care"},{"key":"2104_CR5","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly","year":"2012","unstructured":"Connolly ES, Rabinstein AA, Carhuapoma JR et al (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American stroke association. Stroke 43:1711\u20131737. https:\/\/doi.org\/10.1161\/STR.0b013e3182587839","journal-title":"Stroke"},{"key":"2104_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.drudis.2007.11.010","volume":"13","author":"RW Crowley","year":"2008","unstructured":"Crowley RW, Medel R, Kassell NF, Dumont AS (2008) New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage. Drug Discov Today 13:254. https:\/\/doi.org\/10.1016\/j.drudis.2007.11.010","journal-title":"Drug Discov Today"},{"issue":"6","key":"2104_CR7","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1161\/STROKEAHA.121.035699","volume":"53","author":"M Dayyani","year":"2022","unstructured":"Dayyani M, Sadeghirad B, Grotta JC et al (2022) Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials. Stroke 53(6):1993\u20132005. https:\/\/doi.org\/10.1161\/STROKEAHA.121.035699","journal-title":"Stroke"},{"key":"2104_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10143-006-0045-5","volume":"30","author":"JG de Oliveira","year":"2007","unstructured":"de Oliveira JG, Beck J, Ulrich C, Rathert J, Raabe A, Seifert V (2007) Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev 30:22\u201331. https:\/\/doi.org\/10.1007\/s10143-006-0045-5","journal-title":"Neurosurg Rev"},{"key":"2104_CR9","doi-asserted-by":"publisher","first-page":"CD000277","DOI":"10.1002\/14651858.CD000277.pub3","volume":"2007","author":"SM DorhoutMees","year":"2007","unstructured":"DorhoutMees SM, Rinkel GJ, Feigin VL et al (2007) Calcium antagonists for aneurysmal subarachnoid hemorrhage. Cochrane Database Syst Rev 2007:CD000277. https:\/\/doi.org\/10.1002\/14651858.CD000277.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"2104_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00075198-200204000-00007","volume":"8","author":"NW Dorsch","year":"2002","unstructured":"Dorsch NW (2002) Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 8:128\u2013133. https:\/\/doi.org\/10.1097\/00075198-200204000-00007","journal-title":"Curr Opin Crit Care"},{"key":"2104_CR11","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3171\/2022.2.JNS212914","volume":"137","author":"H Endo","year":"2022","unstructured":"Endo H, Hagihara Y, Kimura N et al (2022) Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg 137:1707\u20131717. https:\/\/doi.org\/10.3171\/2022.2.JNS212914","journal-title":"J Neurosurg"},{"key":"2104_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000475824","volume":"44","author":"M Fujimura","year":"2017","unstructured":"Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T (2017) Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients. Cerebrovasc Dis 44:59\u201367. https:\/\/doi.org\/10.1159\/000475824","journal-title":"Cerebrovasc Dis"},{"key":"2104_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11883-017-0690-x","volume":"19","author":"JR Geraghty","year":"2017","unstructured":"Geraghty JR, Testai FD (2017) Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology. Curr Atheroscler Rep 19:50. https:\/\/doi.org\/10.1007\/s11883-017-0690-x","journal-title":"Curr Atheroscler Rep"},{"issue":"7","key":"2104_CR14","doi-asserted-by":"publisher","first-page":"e0132835","DOI":"10.1371\/journal.pone.0132835","volume":"10","author":"A Hashimoto","year":"2015","unstructured":"Hashimoto A, Tanaka M, Takeda S, Ito H, Nagano K (2015) Cilostazol Induces PGI2 Production via Activation of the Downstream Epac-1\/Rap1 Signaling Cascade to Increase Intracellular Calcium by PLC\u03b5 and to Activate p44\/42 MAPK in Human Aortic Endothelial Cells. PloS one 10(7):e0132835. https:\/\/doi.org\/10.1371\/journal.pone.0132835","journal-title":"PloS one"},{"issue":"1","key":"2104_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.nbd.2008.07.004","volume":"32","author":"H Ito","year":"2008","unstructured":"Ito H, Fukunaga M, Suzuki H, Miyakoda G, Ishikawa M, Yabuuchi Y, Taki W (2008) Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: evaluation using black blood magnetic resonance imaging. Neurobiol Dis 32(1):157\u2013161. https:\/\/doi.org\/10.1016\/j.nbd.2008.07.004","journal-title":"Neurobiol Dis"},{"issue":"2","key":"2104_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/jcbfm.2009.220","volume":"30","author":"H Ito","year":"2010","unstructured":"Ito H, Hashimoto A, Matsumoto Y, Yao H, Miyakoda G (2010) Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats. J Cereb Blood Flow Metab: official journal of the International Society of Cerebral Blood Flow and Metabolism 30(2):343\u2013351. https:\/\/doi.org\/10.1038\/jcbfm.2009.220","journal-title":"J Cereb Blood Flow Metab: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"2104_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3171\/jns.1990.73.1.0037","volume":"73","author":"NF Kassell","year":"1990","unstructured":"Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP (1990) The international cooperative study on the timing of aneurysm surgery part 2: surgical results. J Neurosurg 73:37\u201347. https:\/\/doi.org\/10.3171\/jns.1990.73.1.0037","journal-title":"J Neurosurg"},{"issue":"7","key":"2104_CR18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0271678X18771440","volume":"38","author":"A Klass","year":"2018","unstructured":"Klass A, S\u00e1nchez-Porras R, Santos E (2018) Systematic review of the pharmacological agents that have been tested against spreading depolarizations. J Cereb Blood Flow Metab: official journal of the International Society of Cerebral Blood Flow and Metabolism 38(7):1149\u20131179. https:\/\/doi.org\/10.1177\/0271678X18771440","journal-title":"J Cereb Blood Flow Metab: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"2104_CR19","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1161\/STROKEAHA.109.560243","volume":"40","author":"A Kramer","year":"2009","unstructured":"Kramer A, Fletcher J (2009) Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis. Stroke 40:3403\u20133406. https:\/\/doi.org\/10.1161\/STROKEAHA.109.560243","journal-title":"Stroke"},{"key":"2104_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1385\/NCC:5:3:243","volume":"5","author":"VH Lee","year":"2006","unstructured":"Lee VH, Oh JK, Mulvagh SL, Wijdicks EF (2006) Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care 5:243\u2013249. https:\/\/doi.org\/10.1385\/NCC:5:3:243","journal-title":"Neurocrit Care"},{"key":"2104_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3171\/jns.2006.105.2.264","volume":"105","author":"VH Lee","year":"2006","unstructured":"Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD Jr, Wijdicks EF (2006) Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg 105:264\u2013270. https:\/\/doi.org\/10.3171\/jns.2006.105.2.264","journal-title":"J Neurosurg"},{"issue":"4","key":"2104_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/ijms17040497","volume":"17","author":"BP Lucke-Wold","year":"2016","unstructured":"Lucke-Wold BP, Logsdon AF, Manoranjan B, Turner RC, McConnell E, Vates GE, Huber JD, Rosen CL, Simard JM (2016) Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review. Int J Mol Sci 17(4):497. https:\/\/doi.org\/10.3390\/ijms17040497","journal-title":"Int J Mol Sci"},{"key":"2104_CR23","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1161\/STROKEAHA.108.519942","volume":"39","author":"RL Macdonald","year":"2008","unstructured":"Macdonald RL, Kassell NF, Mayer S et al (2008) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39:3015\u20133021. https:\/\/doi.org\/10.1161\/STROKEAHA.108.519942","journal-title":"Stroke"},{"key":"2104_CR24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","volume":"10","author":"RL Macdonald","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E et al (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping: a randomized, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10:618\u2013625. https:\/\/doi.org\/10.1016\/S1474-4422(11)70108-9","journal-title":"Lancet Neurol"},{"key":"2104_CR25","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/STROKEAHA.111.648980","volume":"43","author":"RL Macdonald","year":"2012","unstructured":"Macdonald RL, Higashida RT, Keller E et al (2012) Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 43:1463\u20131469. https:\/\/doi.org\/10.1161\/STROKEAHA.111.648980","journal-title":"Stroke"},{"issue":"6","key":"2104_CR26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/neurintsurg-2012-010386","volume":"5","author":"CJ McMahon","year":"2013","unstructured":"McMahon CJ, Hopkins S, Vail A, King AT, Smith D, Illingworth KJ, Clark S, Rothwell NJ, Tyrrell PJ (2013) Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. J Neurointerv Surg 5(6):512\u2013517. https:\/\/doi.org\/10.1136\/neurintsurg-2012-010386","journal-title":"J Neurointerv Surg"},{"key":"2104_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/0885066613511054","volume":"30","author":"SB Murthy","year":"2015","unstructured":"Murthy SB, Shah S, Rao CP, Bershad EM, Suarez JI (2015) Neurogenic stunned myocardium following acute subarachnoid hemorrhage: pathophysiology and practical considerations. J Intensive Care Med 30:318\u2013325. https:\/\/doi.org\/10.1177\/0885066613511054","journal-title":"J Intensive Care Med"},{"key":"2104_CR28","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1161\/STROKEAHA.114.004739","volume":"45","author":"T Mutoh","year":"2014","unstructured":"Mutoh T, Kazumata K, Terasaka S, Taki Y, Suzuki A, Ishikawa T (2014) Early intensive versus minimally invasive approach to postoperative hemodynamic management after subarachnoid hemorrhage. Stroke 45:1280\u20131284. https:\/\/doi.org\/10.1161\/STROKEAHA.114.004739","journal-title":"Stroke"},{"key":"2104_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3171\/2015.6.JNS1519","volume":"125","author":"Y Obata","year":"2016","unstructured":"Obata Y, Takeda J, Sato Y, Ishikura H, Matsui T, Isotani E (2016) A multicenter prospective cohort study of volume management after subarachnoid hemorrhage: circulatory characteristics of pulmonary edema after subarachnoid hemorrhage. J Neurosurg 125:254\u2013263. https:\/\/doi.org\/10.3171\/2015.6.JNS1519","journal-title":"J Neurosurg"},{"issue":"9","key":"2104_CR30","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1161\/ATVBAHA.108.164368","volume":"28","author":"H Ota","year":"2008","unstructured":"Ota H, Eto M, Kano MR, Ogawa S, Iijima K, Akishita M, Ouchi Y (2008) Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arterioscler Thromb Vasc Biol 28(9):1634\u20131639. https:\/\/doi.org\/10.1161\/ATVBAHA.108.164368","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2104_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3171\/jns.1996.84.4.0648","volume":"84","author":"RM Pluta","year":"1996","unstructured":"Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH (1996) Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84(4):648\u2013654. https:\/\/doi.org\/10.3171\/jns.1996.84.4.0648","journal-title":"J Neurosurg"},{"key":"2104_CR32","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.wneu.2019.07.016","volume":"131","author":"J Shen","year":"2019","unstructured":"Shen J, Zhu K, Zhu K, Zhou H, Tian H, Yu G (2019) Efficacy of statins in cerebral vasospasm, mortality and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of randomized controlled trials. World Neurosurg 131:e65\u2013e73. https:\/\/doi.org\/10.1016\/j.wneu.2019.07.016","journal-title":"World Neurosurg"},{"key":"2104_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3171\/jns.1992.76.4.0571","volume":"76","author":"M Shibuya","year":"1992","unstructured":"Shibuya M, Suzuki Y, Sugita K et al (1992) Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: results of a prospective placebo-controlled double-blind trial. J Neurosurg 76:571\u2013577. https:\/\/doi.org\/10.3171\/jns.1992.76.4.0571","journal-title":"J Neurosurg"},{"issue":"16","key":"2104_CR34","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1002\/jnr.21807","volume":"86","author":"T Sugawara","year":"2008","unstructured":"Sugawara T, Ayer R, Jadhav V, Chen W, Tsubokawa T, Zhang JH (2008) Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase. J Neurosci Res 86(16):3635\u20133643. https:\/\/doi.org\/10.1002\/jnr.21807","journal-title":"J Neurosci Res"},{"issue":"2","key":"2104_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12975-021-00958-6","volume":"13","author":"H Suzuki","year":"2022","unstructured":"Suzuki H, Kawakita F, Asada R, Nakano F, Nishikawa H, Fujimoto M (2022) Old but Still Hot Target, Glutamate-Mediated Neurotoxicity in Stroke. Transl Stroke Res 13(2):216\u2013217. https:\/\/doi.org\/10.1007\/s12975-021-00958-6","journal-title":"Transl Stroke Res"},{"key":"2104_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-022-01101-9.Advanceonlinepublication.10.1007\/s12975-022-01101-9","author":"H Suzuki","year":"2022","unstructured":"Suzuki H, Miura Y, Yasuda R, Yago T, Mizutani H, Ichikawa T, Miyazaki T, Kitano Y, Nishikawa H, Kawakita F, Fujimoto M, Toma N (2022) Effects of New-Generation Antiepileptic Drug Prophylaxis on Delayed Neurovascular Events After Aneurysmal Subarachnoid Hemorrhage. Transl Stroke Res. https:\/\/doi.org\/10.1007\/s12975-022-01101-9.Advanceonlinepublication.10.1007\/s12975-022-01101-9","journal-title":"Transl Stroke Res"},{"key":"2104_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000327040","volume":"32","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Sayama T, Nakamura T et al (2011) Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report. Cerebrovasc Dis 32:89\u201393. https:\/\/doi.org\/10.1159\/000327040","journal-title":"Cerebrovasc Dis"},{"key":"2104_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.surneu.2006.10.037","volume":"68","author":"Y Suzuki","year":"2007","unstructured":"Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K (2007) A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage. Surg Neurol 68:126\u2013132. https:\/\/doi.org\/10.1016\/j.surneu.2006.10.037","journal-title":"Surg Neurol"},{"key":"2104_CR39","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1097\/CCM.0000000000000163","volume":"42","author":"T Tagami","year":"2014","unstructured":"Tagami T, Kuwamoto K, Watanabe A, Unemoto K, Yokobori S, Matsumoto G, Yokota H, SAH PiCCO Study Group (2014) Optimal range of global end-diastolic volume for fluid management after aneurysmal subarachnoid hemorrhage: a multicenter prospective cohort study. Crit Care Med 42:1348\u20131356. https:\/\/doi.org\/10.1097\/CCM.0000000000000163","journal-title":"Crit Care Med"},{"issue":"8","key":"2104_CR40","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1161\/01.STR.0000176743.67564.5d","volume":"36","author":"MY Tseng","year":"2005","unstructured":"Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ (2005) Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36(8):1627\u20131632. https:\/\/doi.org\/10.1161\/01.STR.0000176743.67564.5d","journal-title":"Stroke"},{"key":"2104_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3171\/jns.2005.103.1.0009","volume":"103","author":"P Vajkoczy","year":"2005","unstructured":"Vajkoczy P, Meyer BS, Raabe A et al (2005) Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 103:9\u201317. https:\/\/doi.org\/10.3171\/jns.2005.103.1.0009","journal-title":"J Neurosurg"},{"key":"2104_CR42","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1212\/01.wnl.0000342471.07290.07","volume":"72","author":"IA van der Bilt","year":"2009","unstructured":"van der Bilt IA, Hasan D, Vandertop WP, Wilde AA, Algra A, Visser FC et al (2009) Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology 72:635\u2013642. https:\/\/doi.org\/10.1212\/01.wnl.0000342471.07290.07","journal-title":"Neurology"},{"key":"2104_CR43","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2165\/00044011-200727110-00006","volume":"27","author":"PL van Giersbergen","year":"2007","unstructured":"van Giersbergen PL, Dingemanse J (2007) Effect of gender on the tolerability, safety and pharmacokinetics of clazosentan following long-term infusion. Clin Drug Invest 27:797\u2013802. https:\/\/doi.org\/10.2165\/00044011-200727110-00006","journal-title":"Clin Drug Invest"},{"key":"2104_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00228-006-0117-z","volume":"63","author":"PL van Giersbergen","year":"2007","unstructured":"van Giersbergen PL, Dingemanse J (2007) Tolerability, pharmacokinetics, and pharmacodynamics of clazosentan, a parenteral endothelin receptor antagonist. Eur J Clin Pharmacol 63:151\u2013158. https:\/\/doi.org\/10.1007\/s00228-006-0117-z","journal-title":"Eur J Clin Pharmacol"},{"key":"2104_CR45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/0885066617732747","volume":"35","author":"LJM Vergouw","year":"2020","unstructured":"Vergouw LJM, Egal M, Bergmans B et al (2020) High early fluid input after aneurysmal subarachnoid hemorrhage: combined report of association with delayed cerebral ischemia and feasibility of cardiac output-guided fluid restriction. J Intensive Care Med 35:161\u2013169. https:\/\/doi.org\/10.1177\/0885066617732747","journal-title":"J Intensive Care Med"},{"key":"2104_CR46","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MDI Vergouwen","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J et al (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41:2391\u20132395. https:\/\/doi.org\/10.1161\/STROKEAHA.110.589275","journal-title":"Stroke"},{"key":"2104_CR47","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/jcbfm.2008.74","volume":"28","author":"MDI Vergouwen","year":"2008","unstructured":"Vergouwen MDI, Vermeulen M, Coert BA, Stroes ES, Roos YB (2008) Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 28:1761\u20131770. https:\/\/doi.org\/10.1038\/jcbfm.2008.74","journal-title":"J Cereb Blood Flow Metab"},{"key":"2104_CR48","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/01.ccm.0000201903.46435.35","volume":"34","author":"KE Wartenberg","year":"2006","unstructured":"Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N et al (2006) Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 34:617\u2013623. https:\/\/doi.org\/10.1097\/01.ccm.0000201903.46435.35. (quiz 24)","journal-title":"Crit Care Med"},{"key":"2104_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-7091-6377-1_3","volume":"72","author":"B Weir","year":"1999","unstructured":"Weir B, Macdonald RL, Stoodley M (1999) Etiology of cerebral vasospasm. Acta Neurochir Suppl 72:27\u201346. https:\/\/doi.org\/10.1007\/978-3-7091-6377-1_3","journal-title":"Acta Neurochir Suppl"},{"issue":"2","key":"2104_CR50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000223439","volume":"28","author":"M Yamaguchi-Okada","year":"2009","unstructured":"Yamaguchi-Okada M, Nishizawa S, Mizutani A, Namba H (2009) Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model. Cerebrovasc Dis (Basel, Switzerland) 28(2):135\u2013142. https:\/\/doi.org\/10.1159\/000223439","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"key":"2104_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10286-004-0186-y","volume":"14","author":"M Zimmermann","year":"2004","unstructured":"Zimmermann M, Seifert V (2004) Endothelin receptor antagonists and cerebral vasospasm. Clin Auton Res 14:143\u2013145. https:\/\/doi.org\/10.1007\/s10286-004-0186-y","journal-title":"Clin Auton Res"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02104-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-023-02104-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02104-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T13:11:27Z","timestamp":1705929087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-023-02104-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2104"],"URL":"https:\/\/doi.org\/10.1007\/s10143-023-02104-2","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"12 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Kariya Toyota General Hospital (approval number: 846), and all procedures were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All experiments were performed according to the relevant guidelines and regulations. Patients were not required to provide informed consent for this study because the analysis used anonymous clinical data obtained after each patient had agreed to treatment by written consent. Furthermore, we used a poster to apply the opt-out method to obtain approval for this study. The Institutional Review Board of Kariya Toyota General Hospital approved the poster.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}